Cargando…

Nitazoxanide May Modify the Course of Progressive Multifocal Leukoencephalopathy

Detalles Bibliográficos
Autores principales:	Hautala, Timo J., Perelygina, Ludmila, Vuorinen, Tytti, Hautala, Nina M., Hägg, Päivi M., Bode, Michaela K., Rusanen, Harri T., Renko, Marjo H., Glumoff, Virpi, Schwab, Nicholas, Schneider-Hohendorf, Tilman, Murk, Jean-Luc, Sullivan, Kathleen E., Seppänen, Mikko R. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2017
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086546/ https://www.ncbi.nlm.nih.gov/pubmed/29159786 http://dx.doi.org/10.1007/s10875-017-0463-x

Ejemplares similares

Inhibition of rubella virus replication by the broad-spectrum drug nitazoxanide in cell culture and in a patient with a primary immune deficiency
por: Perelygina, Ludmila, et al.
Publicado: (2017)

Heterozygous TLR3 Mutation in Patients with Hantavirus Encephalitis
por: Partanen, Terhi, et al.
Publicado: (2020)

Progressive multifocal leukoencephalopathy and black fungus in a patient with rheumatoid arthritis without severe lymphocytopenia
por: de Regt, Marieke J. A., et al.
Publicado: (2016)

Haploinsufficiency of A20 impairs protein–protein interactome and leads into caspase-8-dependent enhancement of NLRP3 inflammasome activation
por: Rajamäki, Kristiina, et al.
Publicado: (2018)

Herpes simplex virus 2 encephalitis in a patient heterozygous for a TLR3 mutation
por: Hautala, Timo, et al.
Publicado: (2020)

Tonsillar granuloma associated with hypogammaglobulinemia
por: Laajala, Aleksi, et al.
Publicado: (2020)

Progressive Multifocal Leukoencephalopathy
por: Adang, Laura, et al.
Publicado: (2015)

Recurrent febrile seizures and serum cytokines: a controlled follow-up study
por: Hautala, Maria K., et al.
Publicado: (2022)

Drug Sensitivity of Vaccine-Derived Rubella Viruses and Quasispecies Evolution in Granulomatous Lesions of Two Ataxia-Telangiectasia Patients Treated with Nitazoxanide
por: Faisthalab, Raeesa, et al.
Publicado: (2022)

Treatment of progressive multifocal leukoencephalopathy
por: Castle, Daniel, et al.
Publicado: (2019)

Meta-Analysis of the Significance of Asymptomatic Bacteriuria in Diabetes
por: Renko, Marjo, et al.
Publicado: (2011)

Progressive multifocal leukoencephalopathy in Finland: a cross-sectional registry study
por: Sipilä, Jussi O. T., et al.
Publicado: (2019)

Progressive Multifocal Leukoencephalopathy in an Immunocompetent Patient?
por: Johansen, Krisztina K., et al.
Publicado: (2013)

Progressive multifocal leukoencephalopathy in an immunocompetent patient
por: van der Kolk, Nicolien M., et al.
Publicado: (2016)

Diagnostic delay in progressive multifocal leukoencephalopathy
por: Miskin, Dhanashri P., et al.
Publicado: (2016)

Progressive multifocal leukoencephalopathy in the absence of immunosuppression
por: Zucker, Benjamin E., et al.
Publicado: (2017)

Progressive Multifocal Leukoencephalopathy: Current Insights
por: Kartau, Marge, et al.
Publicado: (2019)

AIDS-related progressive multifocal leukoencephalopathy
por: Abrão, Carolina de Oliveira, et al.
Publicado: (2020)

Atezolizumab Treatment for Progressive Multifocal Leukoencephalopathy
por: Lambert, Nicolas, et al.
Publicado: (2022)

Advances in Treatment of Progressive Multifocal Leukoencephalopathy
por: Bernard‐Valnet, Raphaël, et al.
Publicado: (2021)

Inflammation and Neutrophil Oxidative Burst in a Family with NFKB1 p.R157X LOF and Sterile Necrotizing Fasciitis
por: Santaniemi, Wenny, et al.
Publicado: (2023)

Heterozygous premature termination in zinc-finger domain of Krüppel-like factor 2 gene associates with dysregulated immunity
por: Pernaa, Nora, et al.
Publicado: (2022)

Rituximab-Associated Inflammatory Progressive Multifocal Leukoencephalopathy
por: Punch, Chandra, et al.
Publicado: (2016)

Progressive multifocal leukoencephalopathy in non-HIV patient
por: Vieira, Diego Rosseman, et al.
Publicado: (2016)

Progressive Multifocal Leukoencephalopathy after Treatment with Nivolumab
por: Martinot, Martin, et al.
Publicado: (2018)

Progressive multifocal leukoencephalopathy after fingolimod treatment
por: Berger, Joseph R., et al.
Publicado: (2018)

Natalizumab: Progressive multifocal leukoencephalopathy: case report
Publicado: (2021)

Innovative therapeutic concepts of progressive multifocal leukoencephalopathy
por: Möhn, Nora, et al.
Publicado: (2022)

Progressive multifocal leukoencephalopathy without overt immunosuppression
por: Jain, Varun, et al.
Publicado: (2023)

Milky Way Sign in Progressive Multifocal Leukoencephalopathy
por: Agarwal, Ayush, et al.
Publicado: (2022)

Drug-associated progressive multifocal leukoencephalopathy: a clinical, radiological, and cerebrospinal fluid analysis of 326 cases
por: Maas, Roderick P. P. W. M., et al.
Publicado: (2016)

Spectral fusion-based breathing frequency estimation; experiment on activities of daily living
por: Alikhani, Iman, et al.
Publicado: (2018)

Evolution of progressive multifocal leukoencephalopathy in HIV-infected patients
por: Iancu, Ana Maria, et al.
Publicado: (2014)

Holmes tremor in a patient with progressive multifocal leukoencephalopathy
por: Gunness, Vimal Raj Nitish, et al.
Publicado: (2014)

Progressive multifocal leukoencephalopathy during fumarate monotherapy of psoriasis
por: Hoepner, Robert, et al.
Publicado: (2015)

Is There a (Host) Genetic Predisposition to Progressive Multifocal Leukoencephalopathy?
por: Hatchwell, Eli
Publicado: (2015)

Progressive Multifocal Leukoencephalopathy and Monoclonal Antibodies: A Review
por: Bohra, Chandrashekar, et al.
Publicado: (2017)

Posterior Fossa Progressive Multifocal Leukoencephalopathy Secondary to Rituximab
por: Guduru, Mounika, et al.
Publicado: (2020)

Germline Genetic Risk Variants for Progressive Multifocal Leukoencephalopathy
por: Eis, Peggy S., et al.
Publicado: (2020)

Pembrolizumab for progressive multifocal leukoencephalopathy due to primary immunodeficiency
por: Küpper, Clemens, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fahd0pf1mu4gtm92i2gkhojf2o